Resting aortic stiffness (pulse wave velocity; aortic PWV (aPWV)) independently predicts end-organ damage and mortality. Exercise haemodynamics have been shown to unmask cardiovascular abnormalities, otherwise undetectable at rest, but the response of aPWV to exercise has never been examined. This study aimed to develop a technique to measure exercise aPWV, determine reproducibility and relation to subclinical end-organ damage with aging. Healthy younger (n ¼ 17, 30±8 years) and older (n ¼ 18, 54 ± 8 years) untreated men underwent cardiovascular assessment at rest and during low intensity semirecumbent cycling. Tonometry was used to assess aPWV and central blood pressure (BP). All participants underwent 24 h ambulatory BP (ABP) monitoring. Kidney function was assessed by estimated glomerular filtration rate (eGFR). Fifteen participants had testing repeated within 28 ± 18 days. Exercise aPWV had good reproducibility (mean difference ¼ À 0.35 ± 0.61 m s À 1 , intraclass correlations ¼ 0.874, Po0.001) and was increased 26% above resting values in younger men (5.8 ± 0.9 vs 7.3 ± 1.6 m s À 1 , Po0.001) and 19% above resting values in older men (6.3±1.0 vs 7.4±0.9 m s À 1 , Po0.001). Exercise, but not resting, aPWV was significantly correlated with eGFR in older men (r ¼ À 0.633, P ¼ 0.005), and this was maintained after correction for age, body mass index and daytime systolic ABP (r ¼ À 0.656, P ¼ 0.008). Conversely, in younger men there was no significant association between eGFR and aPWV either at rest (r ¼ À 0.031, P ¼ 0.906) or during exercise (r ¼ À 0.117, P ¼ 0.655). Exercise aPWV is reproducible and significantly associated with kidney function in healthy older men. Further studies to determine the physiology and clinical relevance of raised exercise aPWV are warranted.
INTRODUCTION
Carotid-to-femoral pulse wave velocity (aortic PWV, (aPWV)) is the gold standard technique to assess central artery stiffness, 1 and is an independent predictor of end-organ damage and mortality. 2 As such, there is considerable interest in determining the underlying pathophysiology and clinical significance of increased aPWV. A recent meta-analysis found that age and mean arterial blood pressure (BP) were the primary determinants of resting aPWV. 3 Furthermore, many studies have found a relationship between aPWV, kidney function and albuminuria. [4] [5] [6] However, these data include aPWV measures taken under resting conditions only. There is now significant evidence to show that ambulatory BP (ABP) 7 or the BP response to exercise 8, 9 holds stronger prognostic value than corresponding resting values. Thus, exercise testing (even at light to moderate intensity) may be a valuable tool to 'unmask' otherwise undetectable cardiovascular abnormalities. [10] [11] [12] [13] Many studies have quantified the large artery responses to exercise and made significant contributions towards understanding the clinical significance of exercise haemodynamics. 14, 15 Indeed, two recent studies found that exaggerated exercise BP was associated with higher resting aortic stiffness and albuminuria. 16, 17 However, to our knowledge, aPWV has never been measured during exercise before. This would seem to be an important goal given the strong connection between ambulatory/ exercise haemodynamics and cardiovascular mortality, and also because most individuals spend a large proportion of their day in an ambulatory state. 18 Therefore, for the first time, we sought to develop and describe a technique to measure light exercise PWV. This study also aimed to determine the reproducibility and clinical significance (by relation to subclinical end-organ damage and age) of exercise aPWV in a cohort of carefully screened healthy men.
MATERIALS AND METHODS

Ethical approval
The study was approved by the University of Tasmania Human Research Ethics Committee. All participants provided written, informed consent and the studies conformed to the standards set by the latest revision of the Declaration of Helsinki.
Study participants
Inclusion criteria were male sex, aged 18-70 years, nondiabetic (by self-report after diagnosis by doctor), nonsmoking, nonobese (body mass index; BMI 18.5-29.9 kg m À 2 ), normotensive (clinic BP p130/80 mm Hg), normocholesterolemic (total serum cholesterol o6.5 mmol l À 1 ) and normoglycemic (fasting blood glucose o5.6 mmol l À 1 ). Subjects were excluded from participation if they reported a clinical history of hypertension, renal or cardiovascular disease, severe pulmonary disease, contraindication to exercise or treatment with vasoactive or glucose lowering medication. Forty-five apparently healthy men were recruited from the community and underwent comprehensive cardiovascular examination at rest and during light exercise. From this examination, 10 participants were excluded from analysis owing to not meeting one or more of the inclusion criteria (n ¼ 3 with cholesterol X6.5 mmol l À 1 , n ¼ 6 with resting clinic BP 4130/80 mm Hg and n ¼ 2 with BMI X30.0 kg m À 2 ), leaving 35 participants in the healthy cohort. From the total population initially recruited (n ¼ 45), 15 participants underwent repeat examination within 28±18 days to assess the reproducibility of exercise PWV. As the clinical data were not considered for inclusion into the reproducibility study, the reproducibility cohort included two participants excluded from the 'healthy' cohort (n ¼ 1 with cholesterol 46.5 mmol l À 1
, and n ¼ 1 with
). There were no significant differences in clinical characteristics between the healthy cohort and the reproducibility cohort (P40.05 for all).
Study design
Participants were instructed to fast overnight (minimum 8 h) and to abstain from caffeinated beverages and alcohol on the day of study, and heavy exercise for 24 h before the study. Fasting venous blood samples were collected (between 0800 and 0900 hours) for determination of routine biochemical analytes. The study took place in a temperature-controlled clinic (23 1C±1 1C) following 15 min rest in the semirecumbent position and a further 5 min without talking. All measurements were performed by one experienced operator (LJK). Sequential measures of brachial and central BP and large artery stiffness were taken at rest and during light exercise on a (semirecumbent) bicycle ergometer, at an intensity designed to mimic a moderate intensity of physical activity, which may be encountered during daily living. For example, leisurely cycling (at four metabolic equivalents) is equivalent to home activities of sweeping the garage, carrying boxes or playing with child(ren) at moderate effort. 19 Cardiac output was monitored continuously throughout the protocol. Before leaving the laboratory, all participants were fitted with a 24 h ABP monitor.
Exercise protocol
Following baseline measurements, a bicycle ergometer (Rehab Trainer 881, MONARK Exercise AB, Vansbro, Sweden) was attached to the end of the bed (supported by a stabilizing board), and the participant remained in the semirecumbent position. Exercise was commenced with two-legged cycling at variable resistance (watts) and cadence (r.p.m.), in order to achieve a steady state heart rate of 60% of age predicted maximum (approximated as 220-age). For each individual undertaking repeat examination for PWV reproducibility, visit 2 exercise workload was set to the level achieved during visit 1. We chose not to define a set cadence, because the most comfortable r.p.m. to achieve a steady state heart rate is a matter of individual preference that may depend on cycling fitness. All variables measured at baseline were repeated in the same order during the exercise protocol.
Brachial BP
Brachial BP was measured in the right arm, using a validated automated oscillometric device (HEM-907, Omron health care, Kyoto, Japan) under resting conditions. 20 Light exercise brachial BP was measured manually using a validated mercury free sphygmomanometer and auscultation (UM-101, A&D Medical, Tokyo, Japan), to minimize possible error due to movement artifact. Brachial BP measurements were recorded twice, at rest and during exercise with the average of the duplicate readings taken as the BP value.
Central BP Central BP was assessed by radial artery applanation tonometry immediately after each brachial BP measure using a hand-held tonometer (SphygmoCor 8.1, AtCor Medical, Sydney, Australia). A generalized transfer function was applied to the radial artery pressure waveforms to allow reconstruction of the central (aortic) pressure waveform. This algorithm has been validated under light exercise conditions. 21 Mean arterial BP was determined by integration of the central pressure waveform. Augmentation index (AIx) was calculated as the difference in pressure between the first and second systolic peaks expressed as a percent of pulse pressure (PP). PP amplification was calculated as the ratio of brachial to central PP.
h ambulatory BP
Each participant underwent 24 h ABP monitoring using a validated oscillometric device (TM-2430, A&D Medical, Sydney, Australia). 22 The monitor was set to obtain readings every 20 min during the participants self-reported waking hours (daytime), and every 30 min during sleep (night time). Participants were instructed not to modify their activities of daily living during the monitoring. The ambulatory arterial stiffness index was calculated from individual 24 h recordings as follows: 1-(regression slope (diastolic BP on systolic BP)). 23 Pulse wave velocity PWV was measured in the right carotid-to-femoral (aPWV) and right carotid-to-radial (brachial PWV) arterial segments using electrocardiogramgated hand-held applanation tonometry (SphygmoCor 8.1). Arterial segment length was estimated by subtracting the transcutaneous distance between the sternal notch and carotid sampling site from the distance between the sternal notch and the distal sampling site (radial or femoral sites).
Femoral artery tonometry of sufficient quality is not possible during cycling exercise due to movement of the lower limbs. In order to record high quality data during the exercise protocol, the tonometry technique was modified as follows; after achievement of steady state plateau at 60% age predicted heart rate maximum, and before all tonometry measurements, the participant was asked to moderately increase r.p.m. in order to achieve a heart rate B10 beats above the set 60% target. The operator (LJK) observed the heart rate via electrocardiogram readout and provided regular feedback to each participant. Once the desired heart rate was achieved, the operator located the arterial pulse (carotid and radial) and placed the tonometer at the site. The participant was then asked to halt pedaling in order for pressure waveform capture to be immediately acquired. This process took B15 s (11 s of arterial wave capture are required for analysis), during which time the participants heart rate declined towards the target heart rate. The process was repeated (after bringing the subject back to steady state) if insufficient waveform quality was obtained. During femoral artery tonometry the participant was instructed to promptly remove their right leg from the bicycle ergometer to enable arterial tonometry. Cycling was resumed immediately following pressure waveform capture, and the participant was brought back to steady state at 60% age predicted maximum heart rate. Although, it is possible to capture pressure waves of high quality from the carotid and radial arterial sites during cycling exercise, to ensure consistency, the above protocol of temporarily stopping exercise to acquire waveforms was applied to all three sampling sites. During both rest and light exercise, the sequential waveforms were acquired within 5 bpm (beats per minute) of each other and duplicate measures were acquired in each arterial segment (aortic and brachial), and then averaged for analysis.
Cardiac output and systemic vascular resistance
Noninvasive haemodynamic monitoring was performed continuously at rest and during light exercise by cardiothoracic bioimpedance (PhysioFlow, PF-05, Manatec Biomedical, Paris, France). Six surface electrodes (Skintact FS50 AgCl, Innsbruck, Austria) were placed at the thorax and neck regions for continuous monitoring of cardiac output, heart rate, stroke volume and systemic vascular resistance. For both rest and exercise periods, stored data were analyzed by averaging 5 min of continuous data, captured during steady state cycling. The PhysioFlow device has been validated against invasive measures (Fick principle), 24 and has good reproducibility during exercise. 25 
Biochemical analysis
Venous blood samples were drawn from the antecubital fossa following an overnight fast. Analytical biochemistry was performed by the Royal Hobart Hospital pathology department using accredited laboratory techniques. Serum creatinine was measured by isotope dilution mass spectrometryaligned technique allowing estimation of the glomerular filtration rate (eGFR) by the revised 175 MDRD (modification of diet in renal disease) equation. 26 
Statistical analysis
Data were analyzed using PASW statistics for Windows (PASW GradPack 18, SPSS Inc. Chicago, IL, USA). Data are presented as mean ± s.d. unless otherwise stated, and Po0.05 was considered statistically significant. All data were assessed for normality of distribution. Within group differences between conditions (rest vs. exercise) were assessed by paired Student's t-test and independent t-tests were used to assess between-group differences. Univariate regression analysis was used to determine correlations between continuous variables. Differences in the strengths of associations (slopes) were assessed by calculation of Z statistic scores. Partial correlation analysis was used to correct for possible confounding Exercise aortic stiffness LJ Keith et al variables. Comparison of measurements for the reproducibility study was assessed by Bland-Altman analysis, 27 Pearson's correlations and intraclass correlations. The intraclass correlations is a measure of reliability that is a ratio of variances derived from repeated measures analysis of variance.
RESULTS
Clinical characteristics and exercise haemodynamics
The clinical characteristics of the healthy younger and older cohorts are detailed in Table 1 . Delineation of age cohorts was based on the median age of the group (43 years). Older men had significantly greater glycated hemoglobin levels when compared with the younger men, otherwise there were no significant differences between age cohorts. All values of serum creatinine were within the normal range (younger: 65-105 mmol l À 1 ; older: 64-90 mmol l À 1 ). Table 2 summarizes the resting and exercise haemodynamics of the two age cohorts. At rest, older men had higher central systolic BP, brachial PWV, AIx and systemic vascular resistance, but lower cardiac output, brachial PP and PP amplification (Po0.05 for all). During exercise, AIx was higher in older men (P ¼ 0.004). There were no other significant differences in exercise haemodynamics between age cohorts.
In older individuals, all haemodynamic variables, including aortic and brachial PWV changed significantly from resting to exercise conditions (Po0.05 for all, Table 2 ). However, brachial PWV did not change significantly in the younger cohort. Figure 1 shows the individual PWV response to light exercise. On average, exercise aPWV was 26 ± 20% higher than resting aPWV in the younger cohort and 19±13% higher than resting aPWV in the older cohort. Exercise brachial PWV was 9±11% lower than resting values in the older cohort, and the percentage change in brachial PWV from resting values was significantly different between the two age cohorts (P ¼ 0.015). There was no difference in aPWV response between the healthy younger and older cohorts (P ¼ 0.226).
Univariate correlates of exercise aPWV: relation to end-organ damage Table 3 shows the univariate correlates of exercise aPWV. In the older cohort, exercise aPWV was significantly correlated with eGFR ( Figure 2 ), serum creatinine, exercise mean arterial BP, exercise central BP, brachial systolic BP and diastolic BP, but not to exercise central or brachial PP. Conversely, in the younger cohort, exercise brachial PWV was the sole correlate of exercise aPWV (r ¼ 0.695, P ¼ 0.002), with no association between eGFR and exercise aPWV either at rest (r ¼ À 0.031, P ¼ 0.906) or during exercise (r ¼ À 0.117, P ¼ 0.655). The regression coefficients (of the relation between exercise aPWV and eGFR) were significantly different between the two age cohorts (Z ¼ 2.16, P ¼ 0.049). There was no relationship between eGFR and exercise aPWV when the two cohorts were analyzed together (r ¼ À 0.240, P ¼ 0.163).
Importantly, the relationship between exercise aPWV and eGFR in the older cohort remained after controlling for ABP (daytime 'awake' systolic ABP), age and BMI (r ¼ À 0.656, P ¼ 0.008), and also remained significant after considering both resting and exercise mean arterial BP as additional confounders in separate models (rest: r ¼ À 0.619, P ¼ 0.018; exercise: r ¼ À 0.640, P ¼ 0.014). On the other hand, the correlation between resting aPWV and eGFR in the older cohort was not statistically significant (r ¼ À 0.400, P ¼ 0.100), which remained similar after correction for age and mean arterial BP (r ¼ À 0.455, P ¼ 0.077). Exercise PWV reproducibility Table 4 shows the reproducibility data of brachial and aPWV. For both aortic and brachial PWV, there were strong correlations and small mean differences between data acquired at the two visits during rest and also during exercise (Figure 3 ). There were no differences in systolic BP, diastolic BP or mean arterial BP between the two visits, at rest (systolic BP 120±11 vs 119±10, P ¼ 0.786; diastolic BP 66 ± 11 vs 67 ± 11, P ¼ 0.270; mean BP 84 ± 12 vs 84 ± 11, P ¼ 0.667) or during exercise (systolic BP 147 ± 10 vs 147±11, P ¼ 0.913; diastolic BP 79±9 vs 79±10, P ¼ 0.901; mean BP 97±9 vs 99±10, P ¼ 0.361). Resting heart rate was lower on visit 2 (60 ± 12 vs 57 ± 11, P ¼ 0.025), but there was no difference in exercise heart rate between the two visits (91 ± 10 vs 91 ± 11, P ¼ 0.664).
The widest variability in PWV was evident for resting brachial PWV. Because of a tendency of exercise aPWV to be marginally lower at the second visit, there was a statistically significant difference between the two visits by paired t-test. Despite this, the limits of agreement for exercise aPWV were better than at rest.
DISCUSSION
To our knowledge, this is the first study to measure exercise aPWV and assess its possible clinical relevance. The main novel finding was that light exercise induced a reproducible increase in aPWV. Moreover, in older men, exercise aPWV was significantly related to kidney function (as determined by eGFR). Importantly, the correlation between exercise aPWV and eGFR remained after correcting for other variables related to risk for end-organ damage including age, BMI, 24 h ABP, resting and exercise mean arterial BP. We speculate that this finding may represent a novel mechanism relating exercise central haemodynamics to end-organ damage. Exercise central haemodynamics and end-organ damage Advancing age is known to be accompanied by stiffening of the large arteries and decline in glomerular and cardiovascular function 28 however, the mechanisms remain unclear. In this cohort of healthy ageing men, exercise aPWV was significantly related to eGFR and also to several measures of exercise central haemodynamics, including central systolic, diastolic and mean arterial BP. Although, this study cannot attribute cause and effect, these data suggest that increased exercise aortic stiffness may result in adverse organ function from raised steady state components of exercise BP. The lack of association between exercise aPWV and brachial or central PP implies a minimal effect of exercise aortic stiffness on the pulsatile component of exercise BP.
To our knowledge, the clinical significance of exercise central haemodynamics has never been assessed. However, Tsiachris et al. 16 found that in 99 never treated patients with hypertension, an exaggerated brachial BP response to treadmill exercise was associated with increased resting aPWV. Similarly, in 171 untreated males with hypertension, those with a hypertensive response to exercise displayed higher aortic stiffness and albuminuria, after correction for age, BMI, resting BP and other markers related to risk for end-organ damage. 17 These results, in conjunction with our observation that exercise rather than resting aPWV was a stronger determinant of kidney function, suggest a possible role of exercise aortic stiffness in the early development of end-organ damage.
Studies in various populations have consistently reported a relation of aortic stiffness and kidney function under resting conditions. [4] [5] [6] Patients with end-stage renal disease show increased aortic stiffness, independent from mean arterial BP and other cardiovascular risk factors 29 and progression of aortic stiffness in hypertensive patients has been shown to correlate with serum creatinine levels. 30 These results suggest a role of aortic stiffness in the decline of renal function through mechanisms which are independent of resting brachial BP. Whether or not exercise aortic stiffness have a role in this mechanism remains to be elucidated.
Determinants of exercise aPWV A recent meta-analysis found that age and mean arterial BP were the primary determinants of resting aPWV. 3 The observation from this current study that the relationship between exercise aPWV and eGFR remained after controlling for these, suggests that the determinants of exercise aortic stiffness may differ from those at rest. Indeed, although there was a trend towards a correlation between resting aPWV and eGFR in older men, this failed to reach significance; even following correction for age and mean arterial BP. One possible explanation for this disparity may be that at higher physiological BP, differences in load bearing and collagen stiffness occur. Studies in animals have found that at higher transmural pressures, recruitment of collagen fibers in the aorta occurs, resulting in disproportionate (transient) stiffening of the central (compared with peripheral) vasculature. 31 This raises the question as to whether inappropriate aortic stiffening during haemodynamic perturbation (such as that induced during exercise) may potentially represent an early dysfunction contributing to later development of end-organ damage. This notion is further supported by the observation that in this present study, there was no relation of eGFR with exercise systemic (AIx/SVR) or peripheral (brachial PWV) arterial stiffness. We state this, however, with the caveat that there was no difference in exercise aPWV between younger and older men, which could indicate that exercise aPWV is relatively 'fixed' throughout the adult lifespan, yet may hold clinical relevance in older populations. This conjecture, however, needs to be tested in larger longitudinal studies.
Mechanisms relating to aging Renal function declines in 'healthy' aging, and is characterized by a progressive loss of nephron mass, glomerulosclerosis, arteriolarnephrosclerosis and an increase in interstitial volume 32, 33 Brachial BP is known to be a strong, independent determinant of renal function; even within the normal BP limits 34 Whether or not increased exercise aortic stiffness may also have a direct role in moderating renal function in this setting deserves further investigation. The differences in the relationship of exercise aPWV and eGFR between the younger and older cohorts may be a result of the loss of renal functional reserve seen with age. 35 Indeed, dysfunction of the autoregulatory capacity of the kidney in older individuals may allow for greater exposure of the glomerular capillaries to higher hydrostatic pressure, subsequent hyperperfusion and damage to the glomerular networks. 28 This process may be exacerbated during exercise due to inappropriate aortic stiffening, which may drive increases in exercise central BP and give rise to an unfavorable haemodynamic environment. However, this is only conjecture since local parameters within the kidney were not measured.
Limitations
The relatively small subject number could have resulted in significant correlations by chance. Ideally, these findings need confirmation in larger study samples with more clear age delineation. On the other hand, the good reproducibility of exercise aPWV and correlation with eGFR (even after correction for potential confounders), suggests that exercise aPWV may have potential for revealing cardiovascular risk. Additionally, we chose a low intensity exercise protocol in order to mimic activities of daily living, and thereby more accurately portray chronic haemodynamic load. Although, the exercise protocol was designed as a surrogate measure of ambulatory haemodynamics, the values obtained may differ from those, which would be invoked by typical daily ambulation. Finally, the findings may not be extrapolated to other populations beyond healthy men.
In conclusion, this study aimed to determine the reproducibility and clinical significance of exercise aPWV in a cohort of healthy men. We found that exercise aPWV was a reproducible measure and was elevated when compared with resting values. In older men only, exercise aPWV was significantly related to kidney function, independent of other factors related to risk for end-organ damage including 24 h ABP. Further studies to determine the clinical relevance of exercise aPWV are warranted.
What is known about this topic
Resting aortic PWV independently predicts end-organ damage and mortality Exercise blood pressure holds stronger prognostic value than resting values Exercise aortic PWV has never been examined
What this study adds This study presents a novel technique to reproducibly measure exercise aortic PWV Exercise, but not resting, aortic PWV was independently correlated with kidney function in older men
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